184 related articles for article (PubMed ID: 33468471)
1. Assessment of Piperacillin-Tazobactam-Meropenem Synergy against Serine Carbapenemase-Producing
Lawandi A; Leite GC; Cheng MP; Lefebvre B; Longtin J; Lee TC
Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33468471
[TBL] [Abstract][Full Text] [Related]
2. In vitro synergy of β-lactam combinations against KPC-producing Klebsiella pneumoniae strains.
Lawandi A; Leite G; Cheng MP; Lefebvre B; Longtin J; Lee TC
J Antimicrob Chemother; 2019 Dec; 74(12):3515-3520. PubMed ID: 31730163
[TBL] [Abstract][Full Text] [Related]
3. In vitro evaluation of dual carbapenem combinations against carbapenemase-producing Enterobacteriaceae.
Poirel L; Kieffer N; Nordmann P
J Antimicrob Chemother; 2016 Jan; 71(1):156-61. PubMed ID: 26416781
[TBL] [Abstract][Full Text] [Related]
4. [Investigation of carbapenemases in carbapenem-resistant Escherichia coli and Klebsiella pneumoniae strains isolated in 2014 in Turkey].
Çakar A; Akyön Y; Gür D; Karatuna O; Öğünç D; Özhak Baysan B; Çöplü N; Çağatay M; Kılıç A; Baysallar M; Bakıcı Z; Çelik C; Gülay Z; Aydemir Ş; Tünger A; Kılıç H; Erçal BD; Aşçı Toraman Z; Zer Y; Büyüktaş A; Ay S; Aktaş Z; Kayacan Ç; Bayramoğlu G; Aydın F; Dündar D; Hasdemir U; Ayaş R; Yanık K; Günaydın M; Güdücüoğlu H; Parlak M
Mikrobiyol Bul; 2016 Jan; 50(1):21-33. PubMed ID: 27058326
[TBL] [Abstract][Full Text] [Related]
5. Activity of meropenem-vaborbactam against different beta-lactamase producing Klebsiella pneumoniae and Escherichia coli isolates in Iran.
Amereh S; Kelishomi FZ; Ghayaz F; Javadi A; Peymani A; Fardsanei F; Aali E; Nikkhahi F
Acta Microbiol Immunol Hung; 2022 Sep; 69(3):201-208. PubMed ID: 35895481
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing
Zhang W; Guo Y; Li J; Zhang Y; Yang Y; Dong D; Zhu D; He P; Hu F
Antimicrob Resist Infect Control; 2018; 7():142. PubMed ID: 30479755
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of meropenem heteroresistance in Klebsiella pneumoniae carbapenemase (KPC)-producing clinical isolates of K. pneumoniae.
Pournaras S; Kristo I; Vrioni G; Ikonomidis A; Poulou A; Petropoulou D; Tsakris A
J Clin Microbiol; 2010 Jul; 48(7):2601-4. PubMed ID: 20504985
[TBL] [Abstract][Full Text] [Related]
8. Isolation of OXA-48-like carbapenemase-producing Escherichia coli susceptible to piperacillin/tazobactam in a Japanese patient without a history of travel abroad.
Kaneko M; Masuda Y; Sawachika H; Shikata H; Moriyama C; Miura M; Yamamoto H; Nakamura T; Fukumoto K; Utsunomiya Y; Sakai K; Ito Y; Ujike A; Asano Y; Shinomiya H
J Infect Chemother; 2023 May; 29(5):530-533. PubMed ID: 36746274
[TBL] [Abstract][Full Text] [Related]
9. Confronting Ceftolozane-Tazobactam Susceptibility in Multidrug-Resistant Enterobacterales Isolates and Whole-Genome Sequencing Results (STEP Study).
Hernández-García M; García-Fernández S; García-Castillo M; Melo-Cristino J; Pinto MF; Gonçalves E; Alves V; Costa E; Ramalheira E; Sancho L; Diogo J; Ferreira R; Silva T; Chaves C; Pássaro L; Paixão L; Romano J; Cantón R;
Int J Antimicrob Agents; 2021 Feb; 57(2):106259. PubMed ID: 33310115
[TBL] [Abstract][Full Text] [Related]
10. Study of
Zhang W; Guo Y; Yang Y; Dong D; Zheng Y; Zhu D; Hu F
Microb Drug Resist; 2020 Mar; 26(3):204-210. PubMed ID: 31553260
[No Abstract] [Full Text] [Related]
11. Time kill-assays of antibiotic combinations for multidrug resistant clinical isolates of OXA-48 carbapenemase producing Klebsiella pneumoniae.
Erdem F; Díez-Aguilar M; Oksuz L; Kayacan C; Abulaila A; Oncul O; Morosini MI; Cantón R; Aktas Z
Acta Microbiol Immunol Hung; 2022 Sep; 69(3):215-219. PubMed ID: 35895557
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of Carbapenem Resistance Determinants Identified in Meropenem-Nonsusceptible
Kazmierczak KM; Karlowsky JA; de Jonge BLM; Stone GG; Sahm DF
Antimicrob Agents Chemother; 2021 Jun; 65(7):e0200020. PubMed ID: 33972241
[TBL] [Abstract][Full Text] [Related]
13. [The Epidemiology of Carbapenemases in Escherichia coli and Klebsiella pneumoniae Isolated in 2019 in Turkey].
Süzük Yıldız S; Şimşek H; Bakkaloğlu Z; Numanoğlu Çevik Y; Hekimoğlu CH; Kılıç S; Alp Meşe E;
Mikrobiyol Bul; 2021 Jan; 55(1):1-16. PubMed ID: 33590977
[TBL] [Abstract][Full Text] [Related]
14. Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay.
Pournaras S; Vrioni G; Neou E; Dendrinos J; Dimitroulia E; Poulou A; Tsakris A
Int J Antimicrob Agents; 2011 Mar; 37(3):244-7. PubMed ID: 21236643
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of In Vitro Activity of Double-Carbapenem Combinations against KPC-2-, OXA-48- and NDM-Producing
Allander L; Vickberg K; Lagerbäck P; Sandegren L; Tängdén T
Antibiotics (Basel); 2022 Nov; 11(11):. PubMed ID: 36421290
[TBL] [Abstract][Full Text] [Related]
16.
Lasko MJ; Abdelraouf K; Nicolau DP
Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33431414
[TBL] [Abstract][Full Text] [Related]
17. In vivo activity of WCK 4282 (high-dose cefepime/tazobactam) against serine β-lactamase-producing Enterobacterales and Pseudomonas aeruginosa in the neutropenic murine thigh infection model.
Gill CM; Abdelraouf K; Nicolau DP
J Antimicrob Chemother; 2021 Mar; 76(4):993-1000. PubMed ID: 33438033
[TBL] [Abstract][Full Text] [Related]
18. Determination of synergy between sulbactam, meropenem and colistin in carbapenem-resistant Klebsiella pneumoniae and Acinetobacter baumannii isolates and correlation with the molecular mechanism of resistance.
Laishram S; Anandan S; Devi BY; Elakkiya M; Priyanka B; Bhuvaneshwari T; Peter JV; Subramani K; Balaji V
J Chemother; 2016 Aug; 28(4):297-303. PubMed ID: 27461479
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-β-lactamase-producing isolates (SIDERO-WT-2014 Study).
Kazmierczak KM; Tsuji M; Wise MG; Hackel M; Yamano Y; Echols R; Sahm DF
Int J Antimicrob Agents; 2019 Feb; 53(2):177-184. PubMed ID: 30395986
[TBL] [Abstract][Full Text] [Related]
20. Activity of Ceftazidime-Avibactam Alone and in Combination with Ertapenem, Fosfomycin, and Tigecycline Against Carbapenemase-Producing
Ojdana D; Gutowska A; Sacha P; Majewski P; Wieczorek P; Tryniszewska E
Microb Drug Resist; 2019 Nov; 25(9):1357-1364. PubMed ID: 31295055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]